Canada · Delayed Price · Currency is CAD Medexus Pharmaceuticals Statistics
Total Valuation
TSX:MDP has a market cap or net worth of CAD 160.90 million. The enterprise value is 190.60 million.
| Market Cap | 160.90M |
| Enterprise Value | 190.60M |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MDP has 31.43 million shares outstanding. The number of shares has increased by 13.18% in one year.
| Current Share Class | 31.43M |
| Shares Outstanding | 31.43M |
| Shares Change (YoY) | +13.18% |
| Shares Change (QoQ) | -1.43% |
| Owned by Insiders (%) | 8.28% |
| Owned by Institutions (%) | 3.33% |
| Float | 28.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.27 |
| PS Ratio | 1.10 |
| PB Ratio | 2.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.99 |
| P/OCF Ratio | 7.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.98, with an EV/FCF ratio of 9.47.
| EV / Earnings | n/a |
| EV / Sales | 1.30 |
| EV / EBITDA | 7.98 |
| EV / EBIT | 18.91 |
| EV / FCF | 9.47 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.30 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 1.56 |
| Debt / FCF | 1.85 |
| Interest Coverage | 1.41 |
Financial Efficiency
Return on equity (ROE) is -4.68% and return on invested capital (ROIC) is 10.62%.
| Return on Equity (ROE) | -4.68% |
| Return on Assets (ROA) | 3.00% |
| Return on Invested Capital (ROIC) | 10.62% |
| Return on Capital Employed (ROCE) | 7.32% |
| Weighted Average Cost of Capital (WACC) | 13.81% |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | -37,333 |
| Employee Count | 90 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.14 |
Taxes
| Income Tax | -31,242 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +91.05% in the last 52 weeks. The beta is 1.68, so TSX:MDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +91.05% |
| 50-Day Moving Average | 5.00 |
| 200-Day Moving Average | 4.21 |
| Relative Strength Index (RSI) | 57.15 |
| Average Volume (20 Days) | 30,089 |
Short Selling Information
The latest short interest is 136,766, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 136,766 |
| Short Previous Month | 128,926 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:MDP had revenue of CAD 146.70 million and -3.36 million in losses. Loss per share was -0.10.
| Revenue | 146.70M |
| Gross Profit | 93.69M |
| Operating Income | 10.08M |
| Pretax Income | -3.39M |
| Net Income | -3.36M |
| EBITDA | 23.64M |
| EBIT | 10.08M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 7.59 million in cash and 37.28 million in debt, with a net cash position of -29.69 million or -0.94 per share.
| Cash & Cash Equivalents | 7.59M |
| Total Debt | 37.28M |
| Net Cash | -29.69M |
| Net Cash Per Share | -0.94 |
| Equity (Book Value) | 68.26M |
| Book Value Per Share | 2.17 |
| Working Capital | 19.52M |
Cash Flow
In the last 12 months, operating cash flow was 20.21 million and capital expenditures -72,425, giving a free cash flow of 20.13 million.
| Operating Cash Flow | 20.21M |
| Capital Expenditures | -72,425 |
| Depreciation & Amortization | 13.47M |
| Net Borrowing | 5.22M |
| Free Cash Flow | 20.13M |
| FCF Per Share | 0.64 |
Margins
Gross margin is 63.86%, with operating and profit margins of 6.87% and -2.29%.
| Gross Margin | 63.86% |
| Operating Margin | 6.87% |
| Pretax Margin | -2.31% |
| Profit Margin | -2.29% |
| EBITDA Margin | 16.11% |
| EBIT Margin | 6.87% |
| FCF Margin | 13.81% |
Dividends & Yields
TSX:MDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.18% |
| Shareholder Yield | -13.18% |
| Earnings Yield | -2.04% |
| FCF Yield | 12.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for TSX:MDP is 7.25, which is 41.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 7.25 |
| Price Target Difference | 41.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 17.69% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on December 19, 2018. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Dec 19, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
TSX:MDP has an Altman Z-Score of 0.85 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.85 |
| Piotroski F-Score | 5 |